Tag Archives: FTC

Financial Institutions Must Comply with FTC’s Revised “Safeguards Rule” by December 2022

MICHAEL NEWELL—The Federal Trade Commission (“FTC” or “Commission”), created by congressional statute, is empowered to prescribe rules that define with specificity acts or practices in or affecting commerce that are unfair or deceptive and establish requirements designed to prevent such acts or practices. In October 2021, the FTC issued a final rule to amend the […]

Is the End Near for Pharmaceutical Pay-for-Delay Deals?

CHELSEA OLIVERA—The legal and policy momentum to curb pharmaceutical pay-for-delay deals is ramping up. On September 22, 2021, Humana and Centene, two health insurance companies, individually filed lawsuits in the U.S. District Court of New Jersey against Merck, a pharmaceutical manufacturer. The health insurance companies alleged that Merck engaged in anticompetitive “pay-for-delay” practices that caused […]